Dentsply Sirona’s first quarter results reflected a company in the midst of operational transformation, with revenue holding steady year over year but outper...
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year...
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $880 million. ...
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Tuesday after the bell. Here’s what investors should know. Dentsply Siro...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how dental equipment ...
What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Although the S&P 500 is down 3.2% over the past six months, Dentsply Sirona’s stock price has fallen further to $11.47, losing shareholders 9.6% of their cap...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Shares of dental products company Dentsply Sirona (NASDAQ:XRAY)
jumped 13.4% in the afternoon session after the company reported mixed fourth-quarter results, with investors seemingly focusing on a revenue beat while overlooking a weak outlook for the upcoming year.
Dental products company Dentsply Sirona (NASDAQ:XRAY) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.2% year on year to $961 million. On the other hand, the company’s full-year revenue guidance of $3.55 billion at the midpoint came in 3.4% below analysts’ estimates. Its non-GAAP profit of $0.27 per share was 6% below analysts’ consensus estimates.
NEW YORK — In a move that has sent shockwaves through global financial centers, gold prices officially breached the historic $5,000 per ounce mark during early trading on February 23, 2026. The surge represents a tectonic shift in the commodity markets, as the yellow metal—once viewed primarily as a
What a brutal six months it’s been for Dentsply Sirona. The stock has dropped 23.6% and now trades at $12.31, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
